During the past decade, Foundation for Vision Research conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 4 clinical trials were completed. i.e. 44.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Foundation for Vision Research" #1 sponsor was "Hoffmann-La Roche" with 7 trials, followed by "Kodiak Sciences Inc" with 5 trials sponsored, "National Eye Institute (NEI)" with 2 trials sponsored, "EyePoint Pharmaceuticals, Inc." with 1 trials sponsored and "Genentech, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Foundation for Vision Research" #1 collaborator was "CBCC Global Research" with 1 trials as a collaborator, "National Center for Complementary and Integrative Health (NCCIH)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Office of Dietary Supplements (ODS)" with 1 trials as a collaborator and "Santen Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Foundation for Vision Research" are "Diabetic Macular Edema" (4 trials), "Geographic Atrophy" (2 trials), "Neovascular Age-Related Macular Degeneration" (2 trials), "Age Related Macular Degeneration" (1 trials) and "Age-related Macular Degeneration" (1 trials). Many other conditions were trialed in "Foundation for Vision Research" in a lesser frequency.

Most popular intervention types in "Foundation for Vision Research" are "Drug" (16 trials), "Other" (7 trials), "Diagnostic Test" (1 trials), "Dietary Supplement" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (6 trials), "Aflibercept" (5 trials), "KSI-301" (5 trials), "Faricimab" (2 trials) and "Intravitreal Ranibizumab 0.5 mg Injection" (2 trials). Other intervention names were less common.

The vast majority of trials in "Foundation for Vision Research" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Foundation for Vision Research". undefined are not yet recruiting, 2 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Foundation for Vision Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Foundation for Vision Research, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".